Promoting safe prescribing in primary care with a contraceptive vital sign: A cluster-randomized controlled trial

Annals of Family Medicine

Volumn 10, Issue 6, 2012, Pages 516-522

  Schwarz, Eleanor Bimla ^a   Parisi, Sara M ^a   Williams, Sanithia L ^a   Shevchik, Grant J ^a   Hess, Rachel ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Contraception; Health services research; Preconception care; Primary healthcare; Teratogens

Indexed keywords

TERATOGENIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL PRACTICE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOCUMENTATION; FAMILY PLANNING; FEASIBILITY STUDY; FEMALE; HEALTH CARE QUALITY; HUMAN; MIDDLE AGED; PREGNANCY; PRESCRIPTION; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; STATISTICS;

ADOLESCENT; ADULT; CONTRACEPTION BEHAVIOR; DOCUMENTATION; FAMILY PLANNING SERVICES; FEASIBILITY STUDIES; FEMALE; HUMANS; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PREGNANCY; PRESCRIPTIONS; PRIMARY HEALTH CARE; PROGRAM EVALUATION; TERATOGENS; YOUNG ADULT;

EID: 84869231749     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.1404     Document Type: Article

References (23)

1. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health. 2006;38(2):90-96.
2. Schwarz EB, Maselli J, Norton M, Gonzales R. Prescription of teratogenic medications in United States ambulatory practices. Am J Med. 2005;118(11):1240-1249.
3. Andrade SE, Gurwitz JH, Davis RL, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004;191(2):398-407.
4. Schwarz EB, Postlethwaite DA, Hung YY, Armstrong MA. Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women. Ann Intern Med. 2007;147(6):370-376.
5. Schwarz EB, Santucci A, Borrero S, Akers AY, Nikolajski C, Gold MA. Perspectives of primary care clinicians on teratogenic risk counseling. Birth Defects Res A Clin Mol Teratol. 2009;85(10):858-863.
6. Eisenberg DL, Stika C, Desai A, Baker D, Yost KJ. Providing contraception for women taking potentially teratogenic medications: a survey of internal medicine physicians' knowledge, attitudes and barriers. J Gen Intern Med. 2010;25(4):291-297.
7. American Pain Society Quality of Care Committee. Quality improvement guidelines for the treatment of acute pain and cancer pain. JAMA. 1995;274(23):1874-1880.
8. Veterans Health Administration. Pain as the 5th Vital Sign Toolkit. Revised edition. October 2000. http://www.va.gov/PAINMANAGEMENT/docs/TOOLKIT.pdf. Accessed Dec 16, 2011.
9. Hess R, Matthews K, McNeil M, Chang CH, Kapoor W, Bryce C. Health services research in the privacy age. J Gen Intern Med. 2005; 20(11):1045-1049.
10. Hess R, Santucci A, McTigue K, Fischer G, Kapoor W. Patient difficulty using tablet computers to screen in primary care. J Gen Intern Med. 2008;23(4):476-480.
11. Murray DM. Design and Analysis of Group-Randomized Trials. New York, NY: Oxford University Press; 1998.
12. Raudenbush SW, Bryk AS. Hierarchal Linear Models: Applications and Data Analysis Methods. Thousand Oaks, CA: Sage Publications; 2002.
13. National Center for Health Statistics. Table 92: Visits to primary care generalist and specialist physicians, by selected characteristics and type of physician: United States, selected years 1980- 2008. In Health, United States, 2010. http://www.cdc.gov/nchs/data/hus/hus10.pdf. Accessed Dec 16, 2011.
14. Dixon JG, Bognar BA, Keyserling TC, et al. Teaching women's health skills: confi dence, attitudes and practice patterns of academic generalist physician. J Gen Intern Med. 2003;18(6):411-418.
15. Schreiber CA, Harwood BJ, Switzer GE, Creinin MD, Reeves MF, Ness RB. Training and attitudes about contraceptive management across primary care specialties: a survey of graduating residents. Contraception. 2006;73(6):618-622.
16. Dehlendorf C, Levy K, Ruskin R, Steinauer J. Health care providers' knowledge about contraceptive evidence: a barrier to quality family planning care? Contraception. 2010;81(4):292-298.
17. Spagnoletti CL, Rubio DM, McNeil MA. Internal medicine residents' preparedness to care for reproductive-age and pregnant women. Teach Learn Med. 2007;19(3):257-263.
18. Morrical-Kline KA, Walton AM, Guildenbecher TM. Teratogen use in women of childbearing potential: an intervention study. J Am Board Fam Med. 2011;24(3):262-271.
19. Fritsche MD, Ables AZ, Bendyk H. Opportunities missed: improving the rate of contraceptive counseling or provision when prescribing reproductive-aged women potentially teratogenic medications in a family medicine resident clinic. Contraception. 2011;84(4):372-376.
20. Weisman CS. Women's use of health care. In: Falik M, Collins K, eds. Women's Health: the Commonwealth Fund Survey of Women's Health. Baltimore, MD: Johns Hopkins University Press; 1996.
21. Gilchrist VJ, Stange KC, Flocke SA, McCord G, Bourguet CC. A comparison of the National Ambulatory Medical Care Survey (NAMCS) measurement approach with direct observation of outpatient visits. Med Care. 2004;42(3):276-280.
22. Santucci AK, Gold MA, Akers AY, Borrero S, Schwarz EB. Women's perspectives on counseling about risks for medication-induced birth defects. Birth Defects Res A Clin Mol Teratol. 2010;88(1):64-69.
23. Lee JK, Parisi SM, Akers AY, Borrero S, Schwarz EB. The impact of contraceptive counseling in primary care on contraceptive use. J Gen Intern Med. 2011;26(7):731-736.